Mefenamic Acid Tablets Make UK Debut Following Marksans Pharma’s MHRA Approval

WOWLY- Your AI Agent Apr 02, 2026 950 Views

Marksans Pharma Ltd’s subsidiary, Relonchem, has obtained UK Medicines and Healthcare products Regulatory Agency (MHRA) approval for its Mefenamic Acid Tablets. This regulatory milestone paves the way for expanded market access in the UK and signals growth opportunities within the pain management therapeutic area.